Market News (Page 65) - TendieTensor

Market News Page 65 of 161 • 4,002 articles

Dialectical Behavior Therapy Market Set to Surge at 9.67% CAGR by 2034, Rising Adoption and Technological Advancements

GlobeNewswire Inc. • Towards Healthcare

Dialectical Behavior Therapy Market Set to Surge at 9.67% CAGR by 2034, Rising Adoption and Technological Advancements

11/12/2025 11:00 AM • The global dialectical behavior therapy market is projected to grow from USD 1.31 billion in 2025 to USD 3.29 billion by 2034, driven by rising mental health awareness, technological advancements, and expanding digital therapy platforms.

CIFR - Signed two significant long-term deals totaling $8.5 billion with AWS and Fluidstack, including Google's partial backing
ACHC - Mentioned as a key market player without specific performance details

#dialectical behavior therapy #mental health #digital therapy #teletherapy #market growth

Stordata annonce 120 millions d’euros de chiffre d’affaires

GlobeNewswire Inc. • Joël Thouvenin

Stordata annonce 120 millions d’euros de chiffre d’affaires

11/12/2025 10:00 AM • Stordata, a data management solutions provider, reported a revenue increase from 90 million to 120 million euros, driven by growth in cloud solutions, cyber resilience, and strategic partnerships. The company plans further expansion through recruitment, potential acquisitions, and international growth.

AMC - Stock down 99.6% from its high, continuing to lose money ($207 million in first two quarters of 2025), struggling with industry challenges, and unable to return to pre-pandemic ticket sales levels
NTNX - Mentioned as a strategic partnership without specific details about the collaboration's impact

#data management #cloud solutions #cyber resilience #digital transformation #IT infrastructure

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day

GlobeNewswire Inc. • Sutro Biopharma

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day

11/12/2025 10:00 AM • Sutro Biopharma announced the initiation of its Phase 1 study for STRO-004, a Tissue Factor ADC, and selected PTK7 as the target for its first dual-payload candidate STRO-227, showcasing its innovative antibody-drug conjugate platform.

STRO - Company is advancing multiple promising ADC programs, entering clinical trials, and demonstrating platform innovation with potential to transform cancer treatment

#ADC #oncology #clinical trials #cancer therapy #antibody drug conjugates

Transdigm Group Reports Strong OEM, Aftermarket And Defense Market Growth In Q4

Benzinga • Lekha Gupta

Transdigm Group Reports Strong OEM, Aftermarket And Defense Market Growth In Q4

11/12/2025 09:56 AM • TransDigm Group reported strong Q4 financial results with net sales rising 12% to $2.44 billion and adjusted EPS of $10.82, exceeding market expectations. The company saw growth in commercial aftermarket, defense markets, and OEM segments.

TDG - Exceeded financial expectations, reported double-digit growth in multiple market segments, issued special dividend, and projected continued positive market trends in FY26

#earnings #aerospace #defense #aftermarket #OEM

Creative Media Shares Spike On Heels Of $44 Million PG FR Deal

Benzinga • Lekha Gupta

Creative Media Shares Spike On Heels Of $44 Million PG FR Deal

11/12/2025 09:42 AM • Creative Media & Community Trust Corp announced the sale of its lending division to PG FR Holding, LLC for approximately $44 million, expecting net cash proceeds of around $31 million. The transaction supports the company's strategic priorities and will result in leadership changes.

NVDA - Facing potential margin compression and market share erosion as cloud providers develop custom silicon alternatives
CMCT - Company is strengthening its balance sheet, enhancing liquidity, and receiving significant cash proceeds from the asset sale, with stock price surging over 71%

#asset sale #lending division #multifamily portfolio #strategic refinancing

Nuclear Stocks Are Melting Down—Should Investors Panic?

Investing.com • Jordan Chussler

Nuclear Stocks Are Melting Down—Should Investors Panic?

11/12/2025 09:42 AM • Nuclear stocks experienced significant sell-offs last week, driven by broader market corrections in AI-related stocks and investors taking profits, despite strong underlying trends in nuclear energy and AI infrastructure development.

LTBR - Stock plunged nearly 32% over five trading sessions, with speculative interest impacted by market sell-off

#nuclear stocks #AI #data centers #market correction #investment

3 Stocks That Have Made Epic Comebacks in 2025

The Motley Fool • David Jagielski

3 Stocks That Have Made Epic Comebacks in 2025

11/12/2025 09:37 AM • Three stocks - Intel, CVS Health, and Super Micro Computer - have made significant recoveries in 2025 after struggling in 2024, driven by strategic investments, leadership changes, and AI market growth.

INTC - Stock up 85% in 2025, secured U.S. government investment, received $5B investment from Nvidia, showed modest operating profit and revenue growth

#stock recovery #semiconductor #healthcare #AI #turnaround stocks

3 Dependable Non-Tech Stocks Poised for Steady Gains in Uncertain Times

Investing.com • Jesse Cohen

3 Dependable Non-Tech Stocks Poised for Steady Gains in Uncertain Times

11/12/2025 09:31 AM • As AI sector concerns grow, investors are seeking stable non-tech stocks. Three recommended stocks are Coca-Cola, AT&T, and Amcor, which offer reliable earnings, consistent dividends, and attractive valuations outside the tech sector.

KO - Strong Q3 performance with 7% organic revenue growth, 55 consecutive years of dividend increases, trading below 10-year average P/E, and solid financial health score

#non-tech stocks #AI bubble #dividend stocks #portfolio diversification #defensive investing

CBIZ’s 2026 Tax Planning Guide Offers a Roadmap for Smart, Strategic Tax Planning

GlobeNewswire Inc. • Joseph Perry

CBIZ’s 2026 Tax Planning Guide Offers a Roadmap for Smart, Strategic Tax Planning

11/12/2025 09:00 AM • CBIZ has published its 2026 Tax Planning Guide, detailing significant tax law updates from the One Big Beautiful Bill Act (OBBBA), offering strategies for businesses and individuals to navigate new tax provisions affecting research expenses, depreciation, and investment opportunities.

CBZ - Company is proactively providing comprehensive guidance on complex tax law changes, positioning itself as a thought leader in tax strategy and professional services

#tax planning #OBBBA #tax law #business strategy #tax incentives

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire Inc. • Silexion Therapeutics Corp

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

11/12/2025 09:00 AM • Silexion Therapeutics reported strong preclinical results for SIL204, a potential cancer therapy targeting KRAS mutations, raised $9.5 million in financing, and remains on track to initiate Phase 2/3 clinical trials in the first half of 2026.

HKHHY - Successfully raised €1.3 billion in Notes with competitive interest rates, indicating strong financial positioning and market confidence
SLXN - Demonstrated positive preclinical data across multiple cancer types, successfully raised capital, regained Nasdaq listing compliance, and maintained clear progress toward clinical trial initiation

#KRAS #cancer therapy #RNA interference #clinical trials #oncology

LPL Financial Launches Cash Management Account to Seamlessly Integrate Banking and Investing

GlobeNewswire Inc. • Mike Holtschlag

LPL Financial Launches Cash Management Account to Seamlessly Integrate Banking and Investing

11/12/2025 09:00 AM • LPL Financial introduced a new Cash Management Account (CMA) that integrates banking features with investment capabilities, offering clients enhanced financial management with FDIC protection and modern banking tools.

SCGLY - Acted as book runner for the Notes placement, performing a standard financial service role
LPLA - Launching an innovative financial product that provides comprehensive banking and investment solutions, demonstrating strategic growth and client-focused innovation

#wealth management #banking #investment #financial services

ANGRY ORCHARD® HARD CIDER LAUNCHES THE “WORLD’S ANGRIEST” CIDER

GlobeNewswire Inc. • Matt Withington And Joe Gaynor

ANGRY ORCHARD® HARD CIDER LAUNCHES THE “WORLD’S ANGRIEST” CIDER

11/12/2025 09:00 AM • Angry Orchard has released a limited-edition, ultra-spicy hard cider infused with customer anger and hot peppers, offering a unique holiday beverage experience that allows fans to 'channel their frustrations'.

SAN - Acted as book runner for the Notes placement, performing a standard financial service role
SAM - Parent company mentioned without specific context beyond being the producer of Angry Orchard

#hard cider #spicy #holiday release #fan engagement #peppers

Nebius Group Rally May Be Only Half Over as Meta Deal Fuels Hypergrowth Outlook

Investing.com • Thomas Hughes

Nebius Group Rally May Be Only Half Over as Meta Deal Fuels Hypergrowth Outlook

11/12/2025 08:38 AM • Nebius Group reported strong Q3 results with 355.1% year-over-year revenue growth, securing a $3 billion contract with Meta that is expected to drive significant future business expansion and potential stock price appreciation.

NBIS - Strong revenue growth, significant Meta contract, triple-digit revenue forecast, improving balance sheet, and institutional investor interest

#hypergrowth #Meta deal #AI #technology #stock rally

Nvidia Stock Unfazed by SoftBank’s Stake Sale, Upside Still Seen

Investing.com • Thomas Hughes

Nvidia Stock Unfazed by SoftBank’s Stake Sale, Upside Still Seen

11/12/2025 08:34 AM • Despite SoftBank selling a small stake in Nvidia, analysts remain bullish on the stock, citing strong institutional ownership, robust earnings potential, and significant upside in AI-driven market growth.

PTBS - The holding company's name was strategically chosen in 1994, anticipating the bank's future growth and regional expansion
NVDA - Strong institutional ownership (65%), potential for significant stock price growth (up to 250%), robust Q3 earnings expectations, and continued AI market expansion

#Nvidia #SoftBank #AI #stock market #earnings #institutional investment

Market Warning: Portfolio Changes Investors Are Making

The Motley Fool • Mark Roussin, Cpa

Market Warning: Portfolio Changes Investors Are Making

11/12/2025 08:33 AM • The fourth quarter of 2025 presents unique investment challenges, with typical market patterns disrupted. Investors are advised to carefully review their portfolios and consider strategic adjustments amid ongoing market uncertainties.

SPGI - The author mentions adding S&P Global to his portfolio, suggesting a cautiously positive view, but the broader context indicates market uncertainty

#Q4 investing #market volatility #portfolio management #stock market trends

SASE OpsLab Partners with Netskope to Revolutionize SASE Deployment at Scale for Frictionless Customer Experience

GlobeNewswire Inc. • Ubiqube

SASE OpsLab Partners with Netskope to Revolutionize SASE Deployment at Scale for Frictionless Customer Experience

11/12/2025 08:00 AM • UBiqube's SASE OpsLab has integrated with Netskope to provide automated deployment and migration solutions for SASE, enabling faster and more secure large-scale rollouts for enterprise customers.

NTSK - Company is expanding its technology capabilities through strategic partnership, focusing on improving customer experience and reducing operational complexity

#SASE #automation #cloud security #infrastructure #deployment

65% of Developers Expect Their Roles To Be Redefined by AI in 2026

GlobeNewswire Inc. • Nacho De Marco

65% of Developers Expect Their Roles To Be Redefined by AI in 2026

11/12/2025 08:00 AM • A survey of 501 developers reveals AI is transforming software development, with 7 in 10 developers improving technical skills, half reporting better work-life balance, and senior developers expecting significant role redefinition in 2026.

ADBE - Mentioned as a client of BairesDev, with no specific context about their AI strategy

#AI #software development #developer roles #technology transformation #workforce evolution

Interact's Enterprise Employee Experience Platform Adds Agentic AI to Drive Employee Listening at Scale

GlobeNewswire Inc. • Emma Johnson

Interact's Enterprise Employee Experience Platform Adds Agentic AI to Drive Employee Listening at Scale

11/12/2025 08:00 AM • Interact launches new AI-powered features for its Employee Experience Platform, introducing tools like Signal Agent and Recognition Agent to help organizations analyze workplace sentiment, reduce context-switching, and improve employee engagement.

GOOGL - Mentioned as a cloud platform partner for enterprise solutions
IHGP - Introducing innovative AI-driven features to solve workplace communication and productivity challenges

#AI #employee experience #workplace sentiment #intranet #Microsoft Copilot

Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City

GlobeNewswire Inc. • Patrick Nj Schnegelsberg

Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City

11/12/2025 08:00 AM • Picard Medical, parent of SynCardia Systems, will attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York City on November 20, 2025, offering one-on-one investor meetings.

GOOG - Mentioned as a cloud platform partner for enterprise solutions
PMI - Company is actively engaging with investors, showcasing growth potential and transparency through conference participation

#medical technology #artificial heart #investor relations #healthcare innovation

Evaxion announce 2026 financial calendar

GlobeNewswire Inc. • Evaxion A/S

Evaxion announce 2026 financial calendar

11/12/2025 08:00 AM • Evaxion A/S announced its financial calendar for 2026, including key dates for business updates and financial results presentations throughout the year.

MSFT - Mentioned as a cloud platform partner for enterprise solutions
EVAX - The article is a routine financial calendar announcement without significant positive or negative indicators, presenting standard corporate communication about upcoming investor events

#financial calendar #AI-Immunology #vaccine development #investor relations

SailPoint Announces Date of Fiscal Third Quarter 2026 Results Conference Call and Participation in Upcoming Investor Conference

GlobeNewswire Inc. • Sailpoint, Inc.

SailPoint Announces Date of Fiscal Third Quarter 2026 Results Conference Call and Participation in Upcoming Investor Conference

11/12/2025 08:00 AM • SailPoint will report its fiscal third quarter 2026 financial results on December 9, 2025, and will host a conference call and participate in Barclay's 23rd Annual Global Technology Conference.

SAIL - The article is a standard financial results and conference participation announcement without indicating significant positive or negative business performance

#financial results #conference call #investor conference #enterprise identity security

Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

Benzinga • Prnewswire

Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

11/12/2025 07:55 AM • Syra Health reported Q3 2025 financial results, highlighting 96% growth in Population Health segment, improved gross margins to 33%, and reduced net loss by 46% through operational efficiency and cost management.

HSBC - Acted as book runner for the Notes placement, performing a standard financial service role
SYRA - Despite federal spending cuts, the company showed significant improvements in revenue growth, gross margins, and net loss reduction, indicating strategic progress towards profitability

#healthcare #financial results #population health #cost reduction #margins

Climb Channel Solutions Announces Strategic Partnership with Liongard

GlobeNewswire Inc. • Not Specified

Climb Channel Solutions Announces Strategic Partnership with Liongard

11/12/2025 07:00 AM • Climb Channel Solutions has partnered with Liongard to provide managed service providers (MSPs) with advanced asset intelligence and automation tools, enabling better IT infrastructure management and security.

CLMB - Expanding partnership portfolio and offering innovative solutions to enhance MSP capabilities

#partnership #MSP #asset intelligence #automation #IT security

AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

GlobeNewswire Inc. • Alphaton Capital Corp

AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

11/12/2025 07:00 AM • Cyncado Therapeutics and ADDRI are launching an investigator-initiated clinical trial for TT-4, a potential mesothelioma treatment, with planned enrollment of 50 patients in Australia to address the lack of second-line therapy options.

KVUE - Soared 16% following Kimberly-Clark's $48.7 billion takeover announcement
ATON - Supporting subsidiary's clinical development efforts while maintaining diverse business interests

#mesothelioma #clinical trial #TT-4 #A2B receptor antagonist #oncology

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps

GlobeNewswire Inc. • Immatics N.V.

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps

11/12/2025 07:00 AM • Immatics reported promising Phase 1a clinical trial results for two bispecific cancer therapies, IMA402 and IMA401, demonstrating favorable tolerability and deep, durable responses in heavily pre-treated patients with solid tumors across multiple cancer types.

IDXX - Rose 14% after beating Wall Street estimates and raising full-year profit outlook
IMTX - Achieved clinical proof-of-concept for two product candidates, showed promising anti-tumor activity with 30% confirmed objective response rate, and outlined clear development strategies for future clinical trials

#TCR Bispecifics #cancer therapy #PRAME #MAGEA4/8 #immunotherapy